Issue 44
11.05.2018
Business & Investment
- Shopify has plans to dominate the cannabis retail market.
- UK based Isodiol signs agreement to export CBD products internationally.
- Emerging cannabis companies in Europe will face competition from South America.
- Maricann Group closes acquisition of Swiss company Haxxon.
- Organigram is set to acquire 25% of German company Alpha-Cannabis.
- Canadian LP forms joint venture with two Swiss cannabis companies.
- Israeli cannabis firm signs agreement with cosmetics company.
- Kannaway develops ‘cannabis beauty’ range aimed at European consumers.
- Canadian cannabis sales are set to overtake hard-alcohol sales by 2025.
- Cannabis retail will create a boost for local businesses.
Regulation & Politics
- The British Medical Journal argues for legalisation, regulation, and taxation of all drugs.
- Despite recent permits medical cannabis is still limited in Ireland.
- Marches in Peru and Argentina demand new cannabis laws.
- Uruguay has authorised 35,000 recreational cannabis users.
Health & Science
- Could ‘microdosing’ be the future of cannabis consumption?
- Cannabigerol (CBG) is one of the most therapeutic cannabinoids.
- Cannabis users report lower levels of anxiety, depression and stress.
- Does medical cannabis have a shelf life?
- FDA backed cannabis trial for PTSD treatment enters second stage of testing.
- Cannabis could be an effective treatment for Gastroesophageal Reflux Disease.